Allergan plc 4/A SEC Filings

Filed On	Filing
21 Mar 2019	Form 4/A: Coughlin Christopher J, Director Holds 20,000 shares of Ordinary Shares, par value $0.0001
06 Mar 2019	Form 4/A: DArecca James, Chief Accounting Officer Received 1,826 shares as a grant or award ($280K)
06 Feb 2017	Form 4/A: Bisaro Paul, Director Received 7,105 shares as a grant or award ($1.63M) · Gave up 3,411 shares to cover exercise price or tax ($782K) · Acquired 7,105 Ordinary Shares, par value $0.0001 (Derivative Conversion)
04 Mar 2016	Form 4/A: Meury William, EVP & Pres Branded Pharma Received 47,165 shares as a grant or award
30 Jun 2015	Form 4/A: Basgoz Nesli, Director Gave up 334 shares to cover exercise price or tax ($101K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: McDonnell Peter J, Director Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Gallagher Michael R, Director Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: O'Sullivan Patrick J, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Taylor Ronald R, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Bodine Chris W, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Bloem James H, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Weiss Fred G, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Coughlin Christopher J, Director Gave up 334 shares to cover exercise price or tax ($101K) · Received 826 shares as a grant or award ($250K)
30 Jun 2015	Form 4/A: Klema Cathy, Director Gave up 549 shares to cover exercise price or tax ($167K) · Received 826 shares as a grant or award ($250K)
31 Mar 2015	Form 4/A: Saunders Brent L, Director Received 135,507 shares as a grant or award
12 Mar 2014	Form 4/A: Actavis plc, 10% owner and 1 other · JUNIPER PHARMACEUTICALS INC Sold 1,400,000 shares ($8.51M)

Comments